ShadowGraph
Start free trial
SEC filings · customer concentration · HALO

Halozyme Therapeutics's major customers

Halozyme Therapeutics appears in 12 disclosed customer relationships between 2011 and 2020.

0major customers now
—of revenue from them
0listed suppliers depending on it
2011–2020years covered
Free

Get an email when Halozyme Therapeutics's customer concentration changes

When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.

We only use your address for this watch. Double opt-in, see our privacy notice.

Major customers of Halozyme Therapeutics

Customers that Halozyme Therapeutics named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.

Formerly disclosed

CustomerShare of revenueChange vs prior yearHistoryLatest filing
Roche40%last FY 2019FY 2011: 19%FY 2012: 45%FY 2013: 64%FY 2014: 57%FY 2015: 42%FY 2016: 63%FY 2017: 38%FY 2018: 72%FY 2019: 40%9 yearsFY 2019 · filed 24 Feb 2020
ArgenxARGX23%last FY 2019FY 2019: 23%1 yearFY 2019 · filed 24 Feb 2020
Viropharma22%last FY 2011FY 2011: 22%1 yearFY 2011 · filed 28 Feb 2014
Janssen18%last FY 2019FY 2014: 20%FY 2015: 1%FY 2016: 2%FY 2017: 6%FY 2018: 2%FY 2019: 18%6 yearsFY 2019 · filed 24 Feb 2020
Intrexon16%last FY 2011FY 2011: 16%1 yearFY 2011 · filed 28 Feb 2014
Baxalta7%last FY 2018FY 2014: 3%FY 2015: 7%FY 2016: 12%FY 2017: 7%FY 2018: 7%5 yearsFY 2018 · filed 21 Feb 2019
Lilly6%last FY 2016FY 2015: 19%FY 2016: 6%2 yearsFY 2016 · filed 20 Feb 2018
AbbvieABBV4%last FY 2016FY 2015: 17%FY 2016: 4%2 yearsFY 2016 · filed 20 Feb 2018
Baxter3%last FY 2014FY 2011: 42%FY 2012: 17%FY 2013: 10%FY 2014: 3%4 yearsFY 2014 · filed 2 Mar 2015
Alexion1%last FY 2019FY 2017: 13%FY 2018: 3%FY 2019: 1%3 yearsFY 2019 · filed 24 Feb 2020
BMS1%last FY 2019FY 2017: 32%FY 2018: 4%FY 2019: 1%3 yearsFY 2019 · filed 24 Feb 2020
PfizerPFE1%last FY 2014FY 2012: 22%FY 2013: 4%FY 2014: 1%3 yearsFY 2014 · filed 2 Mar 2015

About this data

US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.

All companies · Latest dependency shifts · Bulk data and API